Type 2 Diabetes Trial, By Invitation NCT07389772 Sponsor: bengisu yüksel Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, By Invitation

NCT07389772
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults between 18 and 50 years of age.
  • People who are classified as generally healthy with no serious medical conditions (known as ASA Class I status — confirm with trial site if unsure what this means).
  • People who have been diagnosed with Type 2 diabetes, with a blood sugar control measure (called HbA1c) between 5.5% and 9.0%, confirmed by medical records and lab tests.
  • People who have a specific type of tooth infection (called chronic apical periodontitis) affecting their upper or lower front teeth or lower premolars.
  • Teeth that have had a previous root canal treatment that needs to be redone, and which show a certain level of infection on dental X-ray (a PAI score of 3 or higher — confirm with trial site for details).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have any significant health condition beyond well-controlled health (classified as ASA Class II or higher — confirm with trial site).
  • People who are pregnant or may be pregnant.
  • People who have gum disease affecting one or more teeth (localised or generalised periodontitis).
  • People who have certain inflammatory or immune system conditions, including hepatitis, HIV infection, conditions treated with chemotherapy that affects the immune system, bleeding disorders, Behçet's syndrome, or arthritis.
  • People whose HbA1c blood sugar measure is above 9%.
  • People who have taken antibiotics in the past month, or anti-inflammatory medicines (such as pain or swelling relief drugs) in the past week.
  • People who smoke.
  • People who have gum pockets deeper than 3 mm around the tooth being treated.
  • People who have root resorption (breakdown of the tooth root, either from inside or outside the root).
  • People who have swelling, tenderness when pressing on the area, or a dental abscess opening (fistula) near the tooth being treated.
  • People who have a cracked tooth root or an incompletely formed tooth root.
  • Teeth that cannot be properly isolated using a rubber dam (a dental protective sheet used during treatment) will not be included.
  • Patient information including name, age, gender, contact details, and the tooth being treated will be recorded, and dental X-rays will be taken before treatment to assess the tooth (confirm with trial site regarding data and privacy procedures).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
bengisu yüksel
Registry
ClinicalTrials.gov
Start date
28 January 2026
Est. completion
30 June 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

TLR9 expression levels in periapical exudate and gingival crevicular fluid samples

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov